High-sensitivity C-reactive protein and cognitive function in older women

Jennifer Weuve1, Paul M Ridker, Nancy R Cook

  • 1Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. jweuve@hsph.harvard.edu

Insights

This study found no association between high-sensitivity C-reactive protein (hs-CRP), a marker of inflammation, and cognitive function decline in older women. Further research is needed to clarify the role of inflammation in dementia development.

Area of Science:

  • Neuroscience
  • Epidemiology
  • Immunology

Background:

  • Inflammation is a suspected factor in dementia development.
  • Previous studies on inflammatory markers and cognitive function have yielded inconsistent results.

Purpose of the Study:

  • To investigate the association between plasma high-sensitivity C-reactive protein (hs-CRP) levels and cognitive function in older women.
  • To determine if hs-CRP, an inflammatory marker, is linked to cognitive decline.

Main Methods:

  • Measured plasma hs-CRP levels in 4,231 older women (aged 60-90) from the Women's Health Study.
  • Administered cognitive tests assessing general cognition, verbal memory, and category fluency.
  • Utilized multiple linear regression to analyze cognitive scores across hs-CRP quintiles, adjusting for confounders.

Main Results:

  • A wide distribution of hs-CRP levels was observed, with many participants showing high cardiovascular disease risk levels.
  • No significant association was found between higher hs-CRP levels and poorer performance on cognitive tests.
  • Mean cognitive scores did not differ between women in the highest and lowest hs-CRP quintiles.

Conclusions:

  • The study found no evidence linking hs-CRP, a marker of inflammation, to cognitive function decrements in the studied cohort.
  • These findings suggest that hs-CRP may not be a significant predictor of cognitive decline in older women.
Abstract